Geraldine Edu Email

Scientist II . PIPELINE THERAPEUTICS

Current Roles

Employees:
40
Revenue:
$8M
About
Pipeline Therapeutics is a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for neuroregeneration, including synaptogenesis, remyelination and axonal repair. The company's lead product candidate, PIPE-505, is a small molecule gamma secretase inhibitor (GSI) to treat mild-to-moderate sensorineural hearing loss (SNHL) associated with cochlear synaptopathy. The company also has a portfolio of programs, including PIPE-307, focused on remyelination and axonal repair, to address a range of neurological disorders, including multiple sclerosis.
PIPELINE THERAPEUTICS Address
10578 Science Center Drive
San Diego, CA
United States
PIPELINE THERAPEUTICS Email

Past Companies

Pipeline TherapeuticsScientist II
Inception SciencesSenior Research Associate II
Dart Neuroscience (formerly Helicon Therapeutics)Research Associate III

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.